• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Gynaecol Obstet . Gamma SARS-CoV-2 variant of concern infection repercussions on pregnancy outcomes: A translational cohort study

tetano

Editor, Senior Moderator
Int J Gynaecol Obstet


. 2026 Mar 31.
doi: 10.1002/ijgo.70985. Online ahead of print.
Gamma SARS-CoV-2 variant of concern infection repercussions on pregnancy outcomes: A translational cohort study

Guilherme M Nobrega[SUP] 1 [/SUP], Fabiana Granja[SUP] 2 3 [/SUP], Mariene R Amorim[SUP] 2 [/SUP], Luciana S Mofatto[SUP] 2 [/SUP], Daniel A Toledo-Teixeira[SUP] 2 [/SUP], Julia Forato[SUP] 2 [/SUP], Priscilla P Barbosa[SUP] 2 [/SUP], Jose Paulo S Guida[SUP] 1 [/SUP], Adriana G Luz[SUP] 1 [/SUP], Giuliane J Lajos[SUP] 1 [/SUP], Carolina C Ribeiro-do-Valle[SUP] 1 [/SUP], Gisele A Pedroso[SUP] 4 [/SUP], Kamila C S Krywacz[SUP] 4 [/SUP], Angelica Z Schreiber[SUP] 4 [/SUP], Giuliana D Moreno[SUP] 1 [/SUP], Rodrigo N Angerami[SUP] 5 6 [/SUP], Maria Luiza Moretti[SUP] 5 [/SUP], Rodolfo C Pacagnella[SUP] 1 [/SUP], Renato T Souza[SUP] 1 [/SUP], Jose Guilherme Cecatti[SUP] 1 [/SUP], Rodrigo G Stabeli[SUP] 7 8 [/SUP], Magnun N N Santos[SUP] 4 [/SUP], Fernando R Spilki[SUP] 9 [/SUP], Ester C Sabino[SUP] 10 11 [/SUP], Nuno R Faria[SUP] 11 12 [/SUP], William M de Souza[SUP] 13 [/SUP], Jose Luiz Proenca-Modena[SUP] 2 14 [/SUP], Maria Laura Costa[SUP] 1 [/SUP]


Affiliations
Abstract

Objective: This study conduct viral genome sequencing among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pregnant and postpartum individuals, and investigates disease severity and maternal and perinatal outcomes considering variant of concern (VOC) and non-VOC groups.
Methods: The study was designed as a prospective cohort study of unvaccinated pregnant and postpartum women with SARS-CoV-2 infection diagnosed by quantitative reverse transcription polymerase chain reaction between May 2020 and April 2021 at a maternal referral center. Initially, 111 participants were identified, and 50 presented with conditions for genome sequencing and further analysis. The SARS-CoV-2 genome was subjected to next-generation sequencing in eligible cases. Sociodemographic characteristics, background, and clinical and obstetric outcomes were compared according to the SARS-CoV-2 genomic data (VOC vs. non-VOC).
Results: Among the sequenced cases, 18 were classified as VOC, among which 14 were Gamma cases and four Alpha. Oxygen desaturation, hospitalization, intensive care unit admission, invasive ventilation, and maternal death were significantly higher in SARS-CoV-2 VOC-infected than in non-VOC-infected cases. All three cases of maternal death were classified as VOC, including two Gamma and one Alpha.
Conclusion: Pregnant and postpartum people presented with an increased morbidity and mortality due to COVID-19 caused by SARS-CoV-2 VOC, especially Gamma. The increased risk of clinical severity in the unvaccinated obstetric population underscores the importance of addressing the repercussions of the SARS-CoV-2 genomic evolution.

Keywords: COVID‐19; SARS‐CoV‐2; maternal health; morbidity; pregnancy; translational research.

 
Back
Top Bottom